1 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
2 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
3 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
4 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
5 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
6 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
7 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
8 |
Bristol-Myers Squibb v. Mylan Pharmaceut., et al |
1:01-cv-00414 |
S.D.N.Y. |
|
|
|
|
9 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
10 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
11 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
12 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
13 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
14 |
Merck & Co., Inc. v. Mylan Pharmaceutical |
1:03-cv-01953 |
S.D.N.Y. |
|
|
|
|
15 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
16 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
17 |
Sciele Pharma Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:07-cv-00818 |
D.Del. |
|
|
|
|
18 |
Sciele Pharma Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:07-cv-00818 |
D.Del. |
|
|
|
|
19 |
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Pharmaceuticals, Inc. et al |
1:08-cv-00101 |
N.D.W.Va. |
|
|
|
|
20 |
Warner Chilcott Company, LLC et al v. Mylan Pharmaceuticals Inc. |
1:10-cv-00059 |
N.D.W.Va. |
|
|
|
|
21 |
Warner Chilcott Company, LLC et al v. Mylan Pharmaceuticals Inc. |
1:10-cv-00059 |
N.D.W.Va. |
|
|
|
|
22 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
23 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
24 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
25 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
26 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
27 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
28 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
29 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
30 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
31 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
32 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
33 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
34 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
35 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
36 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
37 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
38 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
39 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
40 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
41 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
42 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
43 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
44 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
45 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
46 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
47 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
48 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
49 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
50 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|